AcuraStem is a pioneering biotechnology company based in Monrovia, CA, specializing in the development of patient-based treatments for neurodegenerative diseases such as sporadic ALS and FTD. They utilize their proprietary disease-modeling platform, iNeuroRx, which is considered the gold standard for discovering effective and broadly-acting treatments.
With a patient-focused approach, AcuraStem leads the way in generating individual patient models that accurately replicate neurodegenerative disease processes. By avoiding over-reliance on animal models, they aim to gain a better understanding of the real human mechanisms driving these diseases, resulting in more effective treatments that can benefit a broader range of patients beyond rare, genetically defined subtypes.
Generated from the website